Cormorant Asset Management, LP G1 Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $20,540 - $31,000	-1,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $22,780 - $40,580	1,000 New	1,000 $1.03 Million
Q1 2019 May 15, 2019	SELL	$14.4 - $21.45 $14.3 Million - $21.3 Million	-994,287 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $5.84 Million - $18.2 Million	353,806 Added 55.24%	994,287 $19 Million
Q3 2018 Nov 14, 2018	SELL	$43.15 - $67.97 $3.43 Million - $5.4 Million	-79,504 Reduced 11.04%	640,481 $33.5 Million
Q1 2018 May 15, 2018	SELL	$19.05 - $41.76 $3.38 Million - $7.41 Million	-177,520 Reduced 19.78%	719,985 $26.7 Million
Q3 2017 Nov 14, 2017	BUY	$12.53 - $27.12 $11.2 Million - $24.3 Million	897,505	897,505 $22.3 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.